Dr. Surks is a physician-scientist with a background in translational medicine and early clinical development, basic cardiovascular research and clinical cardiology. Dr. Surks was most recently head of translational medicine and clinical pharmacology U.S. at Sanofi where he led a team focused on research and early clinical development of molecules across multiple therapeutic areas. Prior to Sanofi, Dr. Surks worked in both translational medicine and cardiovascular clinical development at Merck. Dr. Surks has led or overseen translational medicine and clinical pharmacology in multiple preclinical and clinical programs for cardiovascular diseases, rare diseases, hematology and immunology.
Before joining the pharmaceutical industry in 2009, Dr. Surks was an associate professor of medicine at the Molecular Cardiology Research Institute of Tufts Medical Center and School of Medicine, where he led an NIH-funded laboratory focused on cardiovascular signal transduction pathways and served on the cardiology division clinical faculty.
Dr. Surks trained in cardiology and internal medicine at Tufts Medical Center. Dr. Surks received his B.A. from Wesleyan University in Biology and his M.D. from the Albert Einstein College of Medicine.